Role of a-actinin in Cav1.2 Function
a-肌动蛋白在 Cav1.2 功能中的作用
基本信息
- 批准号:9333166
- 负责人:
- 金额:$ 50.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Role of α-actinin in Cav1.2 Function
Abstract
L-type Ca2+ channels are tightly coupled to gene transcription, control neuronal excitability, and mediate
multiple forms of synaptic plasticity. Yet its cell biology and regulation is remarkably poorly understood. Our
long term interest is to determine the molecular mechanisms that regulate the L-type channel Cav1.2 (e.g.,
Science 293, 98; Science 293, 2205; PNAS 103, 7500; Neuron 78, 483), which is the most prevalent L-type
channel in brain and heart. We recently found that α-actinin binds directly to the IQ motif of the central pore-
forming Cav1.2 subunit α11.2 and augments its surface localization (Neuron 78, 483). We now identify three
point mutations in the IQ motif that individually impair α-actinin binding. Our preliminary electrophysiological
and surface labeling data suggest that impairing α-actinin binding to the IQ motif decreases surface
expression and, unexpectedly, also channel open probability (Po). Aim 1 is the very first comprehensive
analysis of trafficking kinetics of WT and point mutated Cav1.2 through the ER-Golgi-TGN secretory pathway
and endocytic recycling and degradation pathway by surface biotinylation, N-glycosylation analysis and
colocalization with respective markers like BiP and Rab5. Aim 2 is to determine and compare current density,
gating currents, and single channel currents to test whether the α-actinin binding - deficient point mutations of
Cav1.2 have decreased Po. Our structural analysis is guiding charge reversal experiments for unequivocal (!)
assignment of deficits in surface expression and Po in the Cav1.2 mutants to loss of α-actinin binding. We
found that Ca2+ influx specifically through Cav1.2 leads to displacement of α-actinin from the IQ motif by
Ca2+/calmodulin and in parallel to run down of Cav1.2 via endocytosis and reduction in Po. Aim 3 is to unravel
the interplay between α-actinin and calmodulin at the IQ motif to precisely define the molecular mechanisms of
how Ca2+/calmodulin displaces α-actinin and leads to endocytosis and run down of Cav1.2. Aim 4 will test first
the role of α-actinin in neuronal Cav1.2 functions including Ca2+ influx into spines and regulation of gene
expression via NFAT and then why α-actinin association and, fittingly, surface expression of Cav1.2 is
increased in rodent models of senility and Alzheimer’s disease (AD). Increased Cav1.2 channel activity
contributes to senile symptoms and AD (e.g., Science 272, 1017; Science 243, 809). Cav1.2 also plays an
important role in PTSD and dysregulation of Cav1.2 leads to autism spectrum disorders (Cell 119, 19-31). Thus
our work on the functional interplay of Cav1.2 with α-actinin and calmodulin is of high significance for
understanding and ultimately treatment of these brain diseases. On a broader perspective it is of physiological
importance as it will define important aspects that govern the functional availability of Cav1.2 with its manifold
functions in neurons and beyond including learning and memory.
α-肌动蛋白在CAV1.2功能中的作用
抽象的
L型Ca2+通道与基因转录,控制神经元和培养基紧密耦合
多种形式的突触可塑性。然而,其细胞生物学和调节知之甚少。我们的
长期关注是确定调节L型通道CAV1.2的分子机制(例如,
科学293,98;科学293,2205; PNAS 103,7500;神经元78,483),这是最普遍的L型
大脑和心脏的渠道。我们最近发现α-肌动蛋白直接与中央孔的智商基序结合
形成CAV1.2亚基α11.2并增强其表面定位(Neuron 78,483)。我们现在确定三个
智商基序中的点突变会损害α-肌动蛋白结合。我们的初步电生理学
表面标记数据表明,损害α-肌动蛋白与智商基序的结合会下降表面
表达,并且出乎意料地引导开放概率(PO)。 AIM 1是第一个综合
通过ER-Golgi-TGN秘密途径分析WT和点突变Cav1.2的贩运动力学
通过表面生物素化,N-糖基化分析和
与BIP和RAB5等相对标记共定位。目标2是确定和比较电流密度,
门控电流和单通道电流,以测试α-肌动蛋白结合 - 缺陷的点突变
Cav1.2已提前PO。我们的结构分析是指导电荷反向实验(!)(!)
CAV1.2突变体中表面表达和PO的定义分配对α-肌动蛋白结合的丧失。我们
发现Ca2+通过CAV1.2专门影响会导致α-肌动蛋白从IQ基序中位移
Ca2+/钙调蛋白,并平行于Cav1.2通过内吞作用和PO减少。目标3是解开
IQ基序处的α-肌动蛋白和钙调蛋白之间的相互作用,以精确定义分子机制
Ca2+/钙调蛋白如何置换α-肌动蛋白并导致内吞作用并降低Cav1.2。 AIM 4将首先测试
α-肌动蛋白在神经元CAV1.2功能中的作用,包括Ca2+影响脊柱的作用和基因调节
通过NFAT的表达,然后是为什么α-肌动蛋白关联以及恰当地表达Cav1.2的表面表达
啮齿动物敏感性和阿尔茨海默氏病(AD)的啮齿动物模型增加。 CAV1.2通道活动增加
有助于老年符号和广告(例如科学272,1017; Science 243,809)。 cav1.2也扮演
CAV1.2的PTSD和失调的重要作用导致自闭症谱系障碍(细胞119,19-31)。那
我们在CAV1.2与α-肌动蛋白和钙调蛋白的功能相互作用方面的工作对
了解并最终治疗这些脑部疾病。从更广泛的角度来看,它是生理的
重要的是,它将定义重要的方面,以控制Cav1.2的功能可用性
神经元和以后的功能,包括学习和记忆。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
JOHANNES W HELL的其他基金
Postsynaptic Signaling by Norepinephrine and cAMP
去甲肾上腺素和 cAMP 的突触后信号传导
- 批准号:1044591710445917
- 财政年份:2022
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Postsynaptic Signaling by Norepinephrine and cAMP
去甲肾上腺素和 cAMP 的突触后信号传导
- 批准号:1055715110557151
- 财政年份:2022
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Detection of Synaptic Proteins with Fluorescent Molecular Rotor-labeled Peptides
使用荧光分子转子标记肽检测突触蛋白
- 批准号:1006396110063961
- 财政年份:2019
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Dysregulation of Cav1.2 by beta amyloid peptide
β 淀粉样肽导致 Cav1.2 失调
- 批准号:1052173510521735
- 财政年份:2016
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Role of a-actinin in Cav1.2 Function
a-肌动蛋白在 Cav1.2 功能中的作用
- 批准号:99244269924426
- 财政年份:2016
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:89359178935917
- 财政年份:2014
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:90938349093834
- 财政年份:2014
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:88182088818208
- 财政年份:2014
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Signaling by cAMP within Postsynaptic Nanodomains
突触后纳米结构域内的 cAMP 信号传导
- 批准号:84398528439852
- 财政年份:2012
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Signaling by cAMP within postsynaptic nano domains R01NS078792
突触后纳米域内 cAMP 的信号传导 R01NS078792
- 批准号:90664629066462
- 财政年份:2012
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
相似国自然基金
泛素E3连接酶接头蛋白SPOP控制离子通道KCNQ1蛋白稳定性影响心肌细胞复极化的机制研究
- 批准号:81800301
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
磁场对神经元动作电位产生与传导的影响
- 批准号:51507046
- 批准年份:2015
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
钙钟和膜钟对窦房结自律性的影响及与房性心律失常相互作用的机制
- 批准号:81271661
- 批准年份:2012
- 资助金额:69.0 万元
- 项目类别:面上项目
心脏再同步化治疗对失同步化心衰左心室电生理重构的影响
- 批准号:81100126
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
L型钙离子通道的不同亚型在生理状态和尼古丁成瘾状态下对于腹侧被盖区多巴胺细胞放电行为的影响及其机制
- 批准号:31000483
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
评估 NAD 补充剂作为心律失常的新型治疗方法
- 批准号:97650039765003
- 财政年份:2019
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
评估 NAD 补充剂作为心律失常的新型治疗方法
- 批准号:1038146210381462
- 财政年份:2019
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
评估 NAD 补充剂作为心律失常的新型治疗方法
- 批准号:1067126310671263
- 财政年份:2019
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
评估 NAD 补充剂作为心律失常的新型治疗方法
- 批准号:98899919889991
- 财政年份:2019
- 资助金额:$ 50.16万$ 50.16万
- 项目类别:
Role of a-actinin in Cav1.2 Function
a-肌动蛋白在 Cav1.2 功能中的作用
- 批准号:99244269924426
- 财政年份:2016
- 资助金额:$ 50.16万$ 50.16万
- 项目类别: